• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在结肠癌细胞中,氨氯吡咪可抑制人尿激酶受体的表达,而肿瘤坏死因子和佛波酯可诱导其表达。

Human urokinase receptor expression is inhibited by amiloride and induced by tumor necrosis factor and phorbol ester in colon cancer cells.

作者信息

Wang Y, Jones C J, Dang J, Liang X, Olsen J E, Doe W F

机构信息

Division of Clinical Sciences, John Curtin School of Medical Research, Australian National University, Canberra.

出版信息

FEBS Lett. 1994 Oct 17;353(2):138-42. doi: 10.1016/0014-5793(94)01032-3.

DOI:10.1016/0014-5793(94)01032-3
PMID:7926038
Abstract

The modulation of urokinase plasminogen activator receptor (uPAR) gene expression by tumor necrosis factor alpha (TNF alpha), phorbol ester (PMA) and amiloride was studied in three colon cancer cell lines. uPAR mRNA and protein were induced by TNF alpha and by PMA but were inhibited by amiloride at concentrations of 0.1 to 1 mM in the presence or absence of TNF alpha and PMA. Nuclear run-on transcription assay indicated that the effects of amiloride and TNF alpha were mediated at least in part at the transcriptional level, whereas PMA may act in part via a posttranscriptional mechanism. These results suggested that uPAR gene expression is modulated by multiple signal transduction pathways.

摘要

在三种结肠癌细胞系中研究了肿瘤坏死因子α(TNFα)、佛波酯(PMA)和氨氯吡咪对尿激酶型纤溶酶原激活物受体(uPAR)基因表达的调节作用。uPAR mRNA和蛋白在有或无TNFα和PMA的情况下,均可被TNFα和PMA诱导,但在0.1至1 mM浓度的氨氯吡咪作用下受到抑制。核转录活性分析表明,氨氯吡咪和TNFα的作用至少部分是在转录水平介导的,而PMA可能部分通过转录后机制发挥作用。这些结果提示uPAR基因表达受多种信号转导途径的调节。

相似文献

1
Human urokinase receptor expression is inhibited by amiloride and induced by tumor necrosis factor and phorbol ester in colon cancer cells.在结肠癌细胞中,氨氯吡咪可抑制人尿激酶受体的表达,而肿瘤坏死因子和佛波酯可诱导其表达。
FEBS Lett. 1994 Oct 17;353(2):138-42. doi: 10.1016/0014-5793(94)01032-3.
2
Sodium butyrate inhibits expression of urokinase and its receptor mRNAs at both transcription and post-transcription levels in colon cancer cells.
FEBS Lett. 1995 Feb 13;359(2-3):147-50. doi: 10.1016/0014-5793(95)00029-9.
3
Amiloride modulates urokinase gene expression at both transcription and post-transcription levels in human colon cancer cells.氨氯地平在转录和转录后水平上调节人结肠癌细胞中尿激酶基因的表达。
Clin Exp Metastasis. 1995 May;13(3):196-202. doi: 10.1007/BF00132208.
4
Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells.尿激酶受体mRNA的转录后调控:人恶性间皮瘤细胞中一种新型尿激酶受体mRNA结合蛋白的鉴定
Mol Cell Biol. 1997 Mar;17(3):1075-83. doi: 10.1128/MCB.17.3.1075.
5
Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor.内皮细胞凝血特性的调节。佛波醇12-肉豆蔻酸酯13-乙酸酯和肿瘤坏死因子对组织因子、纤溶酶原激活物抑制剂及血栓调节蛋白的调节作用
J Biol Chem. 1989 Dec 5;264(34):20705-13.
6
Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis.人恶性间皮瘤细胞中的尿激酶受体:在肿瘤细胞有丝分裂和蛋白水解中的作用。
Am J Physiol. 1995 Jun;268(6 Pt 1):L972-82. doi: 10.1152/ajplung.1995.268.6.L972.
7
Transcriptional regulation of urokinase-type plasminogen activator receptor by cyclic AMP in PL-21 human myeloid leukemia cells: comparison with the regulation by phorbol myristate acetate.环磷酸腺苷对PL-21人髓系白血病细胞中尿激酶型纤溶酶原激活物受体的转录调控:与佛波酯调控的比较
Thromb Haemost. 1998 Mar;79(3):574-8.
8
Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549.人肺癌细胞系A549中细胞因子和肿瘤启动子对尿激酶型纤溶酶原激活物受体的转录和转录后调控
Biochem J. 1995 Aug 15;310 ( Pt 1)(Pt 1):345-52. doi: 10.1042/bj3100345.
9
A urokinase receptor mRNA binding protein from rabbit lung fibroblasts and mesothelial cells.一种来自兔肺成纤维细胞和间皮细胞的尿激酶受体信使核糖核酸结合蛋白。
Am J Physiol. 1998 Jun;274(6):L871-82. doi: 10.1152/ajplung.1998.274.6.L871.
10
Regulation of two forms of the TNF receptors by phorbol ester and dibutyryl cyclic adenosine 3',5'-monophosphate in human histiocytic lymphoma cell line U-937.
Lymphokine Cytokine Res. 1993 Jun;12(3):149-58.

引用本文的文献

1
Endothelial-specific Enhancer as a Cis Element of Regulation by TNF-alpha, IL-1beta, and VEGF.内皮细胞特异性增强子作为 TNF-α、IL-1β 和 VEGF 调节的顺式元件。
Curr Pharm Des. 2024;30(21):1630-1640. doi: 10.2174/0113816128296376240424072322.
2
The effect of amiloride in decreasing albuminuria in patients with diabetic kidney diseases: a prospective, crossover, open-label study.阿米洛利降低糖尿病肾病患者蛋白尿的效果:一项前瞻性、交叉、开放标签研究。
Ren Fail. 2021 Dec;43(1):452-459. doi: 10.1080/0886022X.2021.1892759.
3
Effect of a synthetic inhibitor of urokinase plasminogen activator on the migration and invasion of human cervical cancer cells in vitro.
尿激酶型纤溶酶原激活物抑制剂对体外培养的人宫颈癌迁移和侵袭的影响。
Mol Med Rep. 2018 Mar;17(3):4273-4280. doi: 10.3892/mmr.2018.8414. Epub 2018 Jan 9.
4
Physiology and pathophysiology of the plasminogen system in the kidney.肾脏中纤溶酶原系统的生理学和病理生理学。
Pflugers Arch. 2017 Nov;469(11):1415-1423. doi: 10.1007/s00424-017-2014-y. Epub 2017 Jun 27.
5
Hexamethylene amiloride engages a novel reactive oxygen species- and lysosome-dependent programmed necrotic mechanism to selectively target breast cancer cells.六亚甲基阿米洛利通过一种新型的活性氧和溶酶体依赖性程序性坏死机制来选择性地靶向乳腺癌细胞。
Cancer Lett. 2016 May 28;375(1):62-72. doi: 10.1016/j.canlet.2016.02.042. Epub 2016 Mar 2.
6
Lipoprotein receptor-related protein 1 regulates collagen 1 expression, proteolysis, and migration in human pleural mesothelial cells.载脂蛋白受体相关蛋白 1 调节人胸膜间皮细胞胶原 1 的表达、蛋白水解和迁移。
Am J Respir Cell Mol Biol. 2012 Feb;46(2):196-206. doi: 10.1165/rcmb.2011-0071OC.
7
Urokinase receptor expression involves tyrosine phosphorylation of phosphoglycerate kinase.尿激酶受体表达涉及磷酸甘油酸激酶的酪氨酸磷酸化。
Mol Cell Biochem. 2010 Feb;335(1-2):235-47. doi: 10.1007/s11010-009-0273-4. Epub 2009 Sep 26.
8
Regulation of urokinase receptor mRNA stability by hnRNP C in lung epithelial cells.肺上皮细胞中hnRNP C对尿激酶受体mRNA稳定性的调控
Mol Cell Biochem. 2005 Apr;272(1-2):107-18. doi: 10.1007/s11010-005-7644-2.
9
A urokinase-derived peptide (A6) increases survival of mice bearing orthotopically grown prostate cancer and reduces lymph node metastasis.一种源自尿激酶的肽(A6)可提高原位生长前列腺癌小鼠的生存率,并减少淋巴结转移。
Am J Pathol. 2003 Feb;162(2):619-26. doi: 10.1016/S0002-9440(10)63855-2.
10
Upregulation of monocyte urokinase plasminogen activator receptor during human endotoxemia.人内毒素血症期间单核细胞尿激酶型纤溶酶原激活物受体的上调
Infect Immun. 2000 Apr;68(4):2156-60. doi: 10.1128/IAI.68.4.2156-2160.2000.